Stimuli-Responsive Nanocarriers: Revolutionizing Site-Specific Drug Release

Smart nano-carriers for drug delivery are opening new frontiers as they respond to stimuli inside the human body and/or from outside as well, with the scope to release the drug at the desired time and place with responsive to stimuli like pH, temperature, enzymes, redox potential, light, ultrasound, and/or magnetic fields. Pathological microenvironments such as, acidic pH in tumor tissues or high glutathione in cancer cells are used by these smart systems to release the drug at a targeted site thus reducing general side effects and improving the therapeutic index. Effective scenarios encompass pH-sensitive disassembly, heating and cooling changes, enzyme catalysed breakage, and redox sensitive bond cleavage in numerous diseases such as cancer, neurological disorders, cardiovascular diseases, and infections. Substances like polymers, lipids and inorganic nanoparticles improve the stability, targeting ability and sensitivity of these carriers. Ligand conjugation enhancements also enhance specificity due to increased receptor overexpression and better uptake and localization of the surface-modified nanoparticles. In the case of oncology, these systems accurately target the tumor microenvironments and in neurology the systems help to cross the blood-brain barrier to exert the drug’s action. Additional areas can also be found in infectious diseases for which controlled release of antibiotics as well as antiviral agents enhances localized therapy and minimizes emergence of resistance patterns. Even though there are some issues limit the development of these nanocarriers such biocompatibility, scalability, and regulatory approval, precision medicine still looks forward to the existence of these nanocarriers. The improvements for the future are the following: the integration of multifunctional characteristics, the usage of artificial intelligence in the designing process, and the long-term safety to increase the clinical relevance and the applicability of the material to the environment. Stimuli-responsive nanocarriers are therefore a step up in the realization of efficient and individualised therapeutic results.

Authors

Institutions

Publication Details

Journal
Medical and Pharmaceutical Journal
Published
2025-01-01
DOI
https://doi.org/10.55940/medphar2025118
Citations
2
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
1.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stimuli-Responsive Nanocarriers: Revolutionizing Site-Specific Drug Release

Sunayana Vikhe, Bhavana R Tambe, Parmeshwar M. Pathade
2 citations
Medical and Pharmaceutical Journal
Nanoparticle-Based Drug Delivery
1.19
article

Stimuli-Responsive Nanocarriers: Revolutionizing Site-Specific Drug Release

Sunayana Vikhe, Bhavana R Tambe, Parmeshwar M. Pathade
article en
2 citations

Abstract

Smart nano-carriers for drug delivery are opening new frontiers as they respond to stimuli inside the human body and/or from outside as well, with the scope to release the drug at the desired time and place with responsive to stimuli like pH, temperature, enzymes, redox potential, light, ultrasound, and/or magnetic fields. Pathological microenvironments such as, acidic pH in tumor tissues or high glutathione in cancer cells are used by these smart systems to release the drug at a targeted site thus reducing general side effects and improving the therapeutic index. Effective scenarios encompass pH-sensitive disassembly, heating and cooling changes, enzyme catalysed breakage, and redox sensitive bond cleavage in numerous diseases such as cancer, neurological disorders, cardiovascular diseases, and infections. Substances like polymers, lipids and inorganic nanoparticles improve the stability, targeting ability and sensitivity of these carriers. Ligand conjugation enhancements also enhance specificity due to increased receptor overexpression and better uptake and localization of the surface-modified nanoparticles. In the case of oncology, these systems accurately target the tumor microenvironments and in neurology the systems help to cross the blood-brain barrier to exert the drug’s action. Additional areas can also be found in infectious diseases for which controlled release of antibiotics as well as antiviral agents enhances localized therapy and minimizes emergence of resistance patterns. Even though there are some issues limit the development of these nanocarriers such biocompatibility, scalability, and regulatory approval, precision medicine still looks forward to the existence of these nanocarriers. The improvements for the future are the following: the integration of multifunctional characteristics, the usage of artificial intelligence in the designing process, and the long-term safety to increase the clinical relevance and the applicability of the material to the environment. Stimuli-responsive nanocarriers are therefore a step up in the realization of efficient and individualised therapeutic results.

Medical and Pharmaceutical JournalVol. 4(2)
Pravara Institute of Medical Sciences (IN)
Openalex Percentile: Top 21%
Nanoparticle-Based Drug Delivery
1.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.